No Data
No Data
tianjin chase sun pharmaceutical (300026.SZ): Currently, the company has no cooperation with Star Beast.
Tianjin Chase Sun Pharmaceutical (300026.SZ) stated on the investor interaction platform that the company currently has no cooperation with the company you mentioned (Stellar Beast).
Tianjin Chase Sun Pharmaceutical (300026.SZ) and related personnel received a warning letter issued by the Tianjin Securities Regulatory Bureau.
Tianjin Chase Sun Pharmaceutical (300026.SZ) announced that the company recently received a letter from the Tianjin Regulatory Bureau of the China Securities Regulatory Commission (...)
Tianjin Chase Sun Pharmaceutical (300026.SZ): Heparin products are mainly exported to Europe, Africa, Asia and other regions.
Tianjin Chase Sun Pharmaceutical (300026.SZ) stated during an investor relations event that the company's heparin products are mainly exported to Europe, Africa, Asia, and other regions.
Hongri Pharmaceutical: 2024 Semi-Annual Report
Hongri Pharmaceutical: 2024 Semi-Annual Report Summary
Tianjin Chase Sun Pharmaceutical (300026.SZ) released its first-half performance, with a net income of 0.148 billion yuan, a decrease of 57.14% year-on-year.
Tianjin Chase Sun Pharmaceutical (300026.SZ) released its semi-annual report for 2024, with revenue reaching 2...